Z vs GENI

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Nov 12, 2026

Z

42.1
AI Score
VS
GENI Wins

GENI

53.7
AI Score

Investment Advisor Scores

Z

42score
Recommendation
HOLD

GENI

54score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric Z GENI Winner
Revenue 2.58B 669.49M Z
Net Income 23.00M -111.58M Z
Gross Margin 74.1% 23.0% Z
Net Margin 0.9% -16.7% Z
Operating Income -34.00M -151.33M Z
ROE 0.5% -15.4% Z
ROA 0.4% -9.9% Z
Total Assets 5.68B 1.13B Z
Cash 768.00M 280.56M Z
Current Ratio 3.13 1.56 Z
Free Cash Flow 235.00M 64.54M Z

Relative Price Performance (Last 90 Days)

Z 1M: +5.4% · 3M: -18.0% GENI 1M: -2.3% · 3M: -19.3%

Current Technical Phase

Z

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 46

RSI (14): 45.8 · Price: $29.47

GENI

Distribution
Trim / tighten stop

Price near a flattening SMA50 (slope -7.9%) with fading momentum, RSI 49

RSI (14): 49.2 · Price: $6.38

Fundamentals Snapshot

Metric Z GENI
Market Cap — —
Forward P/E 13.0 6.0
Trailing P/E — —
Revenue (TTM) — —
Revenue Growth 0.1% 0.6%
Gross Margin 0.7% 0.3%
Operating Margin 0.1% 0.1%
EPS -0.50 -0.61
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, GENI is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.